Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-057642

Pres. & Chief Exec. Officer sold 7,232 shares at $30.02 ($217,105)

  • Pres. & Chief Exec. Officer acquired 1,100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Option exercise 10b5-1 +1,100 $2.39 $2,629 22,579 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −1,100 $30.02 $33,022 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −2,714 $30.02 $81,474 20,355 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −2,306 $30.02 $69,226 17,301 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −278 $30.02 $8,346 11,534 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −278 $30.02 $8,346 11,534 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −278 $30.02 $8,346 11,534 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Sale 10b5-1 −278 $30.02 $8,346 11,534 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-08-14 Option exercise · Stock option (right to buy) 10b5-1 −1,100 37,757 D
Open-market sales · 7,232 sh · avg $30.02 · $217,105
Loading xslF345X06/wk-form4_1787083796.xml…